{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:55:24Z","timestamp":1780480524732,"version":"3.54.1"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"Importance<\/jats:title>Variants in the vitamin D\u2013binding protein (DBP) gene (GC<\/jats:italic>) encode DBP isoforms that may affect vitamin D metabolism. However, whether these isoforms modify the effects of vitamin D3<\/jats:sub> and\/or calcium supplementation on colorectal adenoma recurrence is unclear. We hypothesized that supplementation effects may be stronger among those with the DBP2 isoform (encoded by the rs4588<\/jats:ext-link>*A allele), which is associated with vitamin D deficiency and modified the associations of circulating vitamin D with risk for colorectal neoplasms in observational studies.<\/jats:p><\/jats:sec>Objective<\/jats:title>To estimate supplemental vitamin D3<\/jats:sub> and\/or calcium effects on colorectal adenoma recurrence according to 3 common DBP isoforms (DBP1s, DBP1f, DBP2) encoded by 2 missense variants: rs7041<\/jats:ext-link> (NG_012837<\/jats:ext-link>.3:g.57904T&amp;gt;G NP_001191235<\/jats:ext-link>.1:p.Asp432Glu) and rs4588<\/jats:ext-link> (NG_012837<\/jats:ext-link>.3:g.57915C&amp;gt;A NP_001191235<\/jats:ext-link>.1:p.Thr436Lys).<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>Secondary analysis of a randomized, double-blind, placebo-controlled clinical trial of 2259 participants with a recently diagnosed adenoma and no remaining polyps after complete colonoscopy in the US from July 1, 2004, to August 31, 2013. The current analyses were performed from August 12, 2019, to July 16, 2022.<\/jats:p><\/jats:sec>Interventions<\/jats:title>Daily vitamin D3<\/jats:sub> (1000 IU), calcium (1200 mg), both, or placebo.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>One or more adenomas diagnosed during 3 to 5 years of follow-up. Treatment effects were estimated according to DBP isoform as risk ratios (RRs) and 95% CIs using Poisson regression analysis.<\/jats:p><\/jats:sec>Results<\/jats:title>Of the 2259 participants randomized (mean [SD] age, 58 [6.8] years; 1033 [64%] men), 1604 non-Hispanic White participants (chosen to avoid population stratification bias) were included in the analysis. Among those with the DBP2 isoform (rs4588<\/jats:ext-link>*AC or AA), the RRs (95% CI) for adenoma recurrence were 0.84 (0.72-1.00) with vitamin D3<\/jats:sub> relative to no vitamin D3<\/jats:sub>, 0.83 (95% CI, 0.70-0.99) with calcium relative to no calcium, and 0.76 (95% CI, 0.59-0.98) with both agents relative to neither agent. Conversely, among those without DBP2 (rs4588<\/jats:ext-link>*CC), the corresponding values were 1.08 (95% CI, 0.93-1.26; P<\/jats:italic>\u2009=\u2009.03 for interaction) with vitamin D3<\/jats:sub> relative to no vitamin D3<\/jats:sub>, 0.98 (95% CI, 0.84-1.14; P<\/jats:italic>\u2009=\u2009.37 for interaction) with calcium relative to no calcium, and 1.09 (0.88-1.36; P<\/jats:italic>\u2009=\u2009.03 for interaction) with both agents relative to neither agent. Among DBP2 homozygotes (rs4588<\/jats:ext-link>*AA), the RR for adenoma recurrence was 0.57 (95% CI, 0.31-1.08) with both agents relative to neither agent.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>The findings of this secondary analysis of a randomized clinical trial suggest that individuals with the DBP2 isoform\u2013encoding rs4588<\/jats:ext-link>*A allele may particularly benefit from vitamin D3<\/jats:sub> and\/or calcium supplementation for colorectal adenoma prevention.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT00153816<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoncol.2022.6924","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T16:01:44Z","timestamp":1674748904000},"page":"546","source":"Crossref","is-referenced-by-count":15,"title":["Impact of Common Vitamin D\u2013Binding Protein Isoforms on Supplemental Vitamin D3<\/sub> and\/or Calcium Effects on Colorectal Adenoma Recurrence Risk"],"prefix":"10.1001","volume":"9","author":[{"given":"David Corley","family":"Gibbs","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Barry","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Fedirko","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia"},{"name":"Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Baron","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire"},{"name":"Department of Medicine, University of North Carolina School of Medicine, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberd M.","family":"Bostick","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"16","key":"cbr220030r1","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa1500409","article-title":"A trial of calcium and vitamin D for the prevention of colorectal adenomas.","volume":"373","author":"Baron","year":"2015","journal-title":"N Engl J Med"},{"key":"cbr220030r2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0385"},{"issue":"10","key":"cbr220030r3","doi-asserted-by":"publisher","first-page":"E2133","DOI":"10.1210\/jc.2014-1389","article-title":"Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.","volume":"99","author":"Barry","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"cbr220030r4","doi-asserted-by":"publisher","author":"Gibbs","year":"2018","DOI":"10.1093\/aje\/kwy102"},{"key":"cbr220030r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.03.011"},{"issue":"1","key":"cbr220030r6","article-title":"Association of circulating vitamin D with colorectal cancer depends on vitamin D\u2013binding protein isoforms: a pooled, nested, case-control study.","volume":"4","author":"Gibbs","year":"2019","journal-title":"J Natl Cancer Inst Cancer Spectr"},{"issue":"5","key":"cbr220030r7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/jamaoncol.2016.5917","article-title":"Vitamin D receptor genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial.","volume":"3","author":"Barry","year":"2017","journal-title":"JAMA Oncol"},{"issue":"7","key":"cbr220030r8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data.","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"13","key":"cbr220030r9","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/sim.6856","article-title":"Calibration and seasonal adjustment for matched case-control studies of vitamin D and cancer.","volume":"35","author":"Gail","year":"2016","journal-title":"Stat Med"},{"key":"cbr220030r10","doi-asserted-by":"publisher","DOI":"10.2174\/187152013804487281"},{"issue":"10-11","key":"cbr220030r11","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.clinbiochem.2009.03.008","article-title":"Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation.","volume":"42","author":"Fu","year":"2009","journal-title":"Clin Biochem"},{"issue":"2","key":"cbr220030r12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF00219689","article-title":"Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP).","volume":"92","author":"Arnaud","year":"1993","journal-title":"Hum Genet"},{"issue":"7","key":"cbr220030r13","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2010-0195","article-title":"Vitamin D\u2013binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D.","volume":"95","author":"Chun","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"cbr220030r14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1158\/1940-6207.CAPR-20-0140","article-title":"Inflammation modulation by vitamin D and calcium in the morphologically normal colorectal mucosa of patients with colorectal adenoma in a clinical trial.","volume":"14","author":"Gibbs","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"key":"cbr220030r15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fendo.2019.00171","article-title":"25-Hydroxyvitamin D and vitamin D binding protein levels in patients with primary hyperparathyroidism before and after parathyroidectomy.","volume":"10","author":"Wang","year":"2019","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2800952\/jamaoncology_gibbs_2023_br_220030_1681755697.34638.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T16:44:01Z","timestamp":1682009041000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2800952"}},"subtitle":["A Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2022.6924","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}